Literature DB >> 27921168

The 2016 diagnostic criteria for primary sclerosing cholangitis.

Takahiro Nakazawa1, Kenji Notohara2, Susumu Tazuma3, Atsushi Tanaka4, Hiroyuki Isayama5, Toshio Tsuyuguchi6, Toshiyuki Mori7, Hajime Takikawa4.   

Abstract

BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown cause that is characterized pathologically by an inflammatory and fibrotic process centered on the epithelium, leading to diffuse biliary stenosis and increased wall thickness throughout the intra- and extra-hepatic biliary trees. A nationwide survey in Japan revealed several differences in the clinical aspects of PSC between Japan and Western countries. PSC was recently designated an intractable hepatobiliary disease in Japan. The aim of this study was to establish Japanese diagnostic criteria for PSC according to the current Japanese conditions.
METHODS: The Intractable Hepato-Biliary Diseases Study Group in Japan of the Committee of Research on Measures for Intractable Diseases established a working group consisting of researchers specializing in PSC and proposed the 2016 Japanese diagnostic criteria for PSC.
RESULTS: The diagnostic criteria consisted of the major and minor items. Major items are directly related to bile duct changes based on biliary tract imaging and an increased alkaline phosphatase level. Minor items consist of an association with inflammatory bowel disease and liver histology.
CONCLUSION: The diagnostic criteria for PSC are useful for general physicians in practice.

Entities:  

Keywords:  PSC; Primary sclerosing cholangitis; Sclerosing cholangitis

Mesh:

Substances:

Year:  2016        PMID: 27921168     DOI: 10.1007/s00535-016-1286-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  22 in total

1.  Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.

Authors:  Kirsten Boonstra; Karel J van Erpecum; Karin M J van Nieuwkerk; Joost P H Drenth; Alexander C Poen; Ben J M Witteman; Hans A R E Tuynman; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

2.  Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.

Authors:  Hirotaka Ohara; Kazuichi Okazaki; Hirohito Tsubouchi; Kazuo Inui; Shigeyuki Kawa; Terumi Kamisawa; Susumu Tazuma; Kazushige Uchida; Kenji Hirano; Hitoshi Yoshida; Takayoshi Nishino; Shigeru B H Ko; Nobumasa Mizuno; Hideaki Hamano; Atsushi Kanno; Kenji Notohara; Osamu Hasebe; Takahiro Nakazawa; Yasuni Nakanuma; Hajime Takikawa
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-09       Impact factor: 7.027

3.  Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  Hitoshi Sano; Takahiro Nakazawa; Tomoaki Ando; Kazuki Hayashi; Itaru Naitoh; Fumihiro Okumura; Katsuyuki Miyabe; Michihiro Yoshida; Satoru Takahashi; Hirotaka Ohara; Takashi Joh
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-03       Impact factor: 7.027

4.  Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.

Authors:  Atsushi Tanaka; Susumu Tazuma; Kazuichi Okazaki; Hirohito Tsubouchi; Kazuo Inui; Hajime Takikawa
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-10-29       Impact factor: 7.027

5.  Primary sclerosing cholangitis in Japan--analysis of 192 cases.

Authors:  H Takikawa; T Manabe
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

6.  ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; M Edwyn Harrison
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

7.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

8.  Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients.

Authors:  Hajime Takikawa; Yoriyuki Takamori; Atsushi Tanaka; Hiroko Kurihara; Yasuni Nakanuma
Journal:  Hepatol Res       Date:  2004-07       Impact factor: 4.288

Review 9.  Primary sclerosing cholangitis.

Authors:  Gideon M Hirschfield; Tom H Karlsen; Keith D Lindor; David H Adams
Journal:  Lancet       Date:  2013-06-28       Impact factor: 79.321

10.  The natural history of small-duct primary sclerosing cholangitis.

Authors:  Einar Björnsson; Rolf Olsson; Annika Bergquist; Stefan Lindgren; Barbara Braden; Roger W Chapman; Kirsten M Boberg; Paul Angulo
Journal:  Gastroenterology       Date:  2008-01-17       Impact factor: 22.682

View more
  4 in total

Review 1.  Role of Peroral Cholangioscopy in the Diagnosis of Primary Sclerosing Cholangitis.

Authors:  Toshio Fujisawa; Mako Ushio; Sho Takahashi; Wataru Yamagata; Yusuke Takasaki; Akinori Suzuki; Yoshihiro Okawa; Kazushige Ochiai; Ko Tomishima; Shigeto Ishii; Hiroaki Saito; Hiroyuki Isayama
Journal:  Diagnostics (Basel)       Date:  2020-04-29

2.  Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.

Authors:  Shun-Ichi Wakabayashi; Satoru Joshita; Kazuhiro Kimura; Hirohiko Motoki; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Koichiro Kuwahara; Takeji Umemura
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

3.  Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis.

Authors:  Takanori Suzuki; Itaru Naitoh; Takahito Katano; Kentaro Matsuura; Yoshihito Nagura; Kei Fujiwara; Shunsuke Nojiri; Hiromi Kataoka
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

4.  Clinical guidelines for primary sclerosing cholangitis 2017.

Authors:  Hiroyuki Isayama; Susumu Tazuma; Norihiro Kokudo; Atsushi Tanaka; Toshio Tsuyuguchi; Takahiro Nakazawa; Kenji Notohara; Suguru Mizuno; Nobuhisa Akamatsu; Masahiro Serikawa; Itaru Naitoh; Yoshiki Hirooka; Toshifumi Wakai; Takao Itoi; Tomoki Ebata; Shinji Okaniwa; Terumi Kamisawa; Hiroki Kawashima; Atsushi Kanno; Keiichi Kubota; Masami Tabata; Michiaki Unno; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2018-06-27       Impact factor: 7.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.